Innovus Pharma (INNV) Earnings
|
Expand Research on INNV
| Next EPS Date | 9/9/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +25.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.7% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/12/26  |
Q326 | N/A | $0.05 | N/A | N/A | $234.53M | N/A | N/A | N/A | ||
| 2/3/26 |
Q226 | N/A | $0.04 | N/A | N/A | $228.4M | N/A | N/A | N/A | ||
| 11/4/25 |
Q126 | $0.06 | $0.02 | +$0.04 | $236.1M | $226.56M | N/A |  | | Details | |
| 9/9/25 |
Q425 | N/A | -$0.01 | N/A | N/A | $220.39M | = | N/A | N/A | ||
| 5/6/25 |
Q325 | N/A | -$0.01 | N/A | N/A | $214.09M | = | N/A | N/A | ||
| 2/4/25 | Q225 | -$0.10 | $0.00 | -$0.10 | $208.99M | $209.73M | = | | | Details | |
| 11/5/24 |
Q125 | N/A | -$0.04 | N/A | N/A | $203.11M | = | N/A | N/A | ||
| 9/10/24 | Q424 | N/A | -$0.02 | N/A | N/A | $191.43M | N/A | N/A | N/A |
